3-乙酰基-2-氯-1-甲基吲哚结构式
|
常用名 | 3-乙酰基-2-氯-1-甲基吲哚 | 英文名 | 1-(2-chloro-1-methylindol-3-yl)ethanone |
|---|---|---|---|---|
| CAS号 | 65287-75-4 | 分子量 | 207.65600 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C11H10ClNO | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | 3-乙酰基-2-氯-1-甲基吲哚 |
|---|---|
| 英文名 | 1-(2-chloro-1-methylindol-3-yl)ethanone |
| 英文别名 | 更多 |
| 分子式 | C11H10ClNO |
|---|---|
| 分子量 | 207.65600 |
| 精确质量 | 207.04500 |
| PSA | 22.00000 |
| LogP | 3.03430 |
|
~94%
3-乙酰基-2-氯-1-甲基吲哚 65287-75-4 |
| 文献:Deng; Konopelski Organic letters, 2001 , vol. 3, # 19 p. 3001 - 3004 |
|
~%
3-乙酰基-2-氯-1-甲基吲哚 65287-75-4 |
| 文献:Novo Nordisk A/S Patent: US5783575 A1, 1998 ; US 5783575 A Title/Abstract Full Text Show Details Novo Nordisk A/S Patent: US5536721 A1, 1996 ; US 5536721 A |
|
~70%
3-乙酰基-2-氯-1-甲基吲哚 65287-75-4 |
| 文献:Monge; Palop; Ramirez; Font; Fernandez-Alvarez European Journal of Medicinal Chemistry, 1991 , vol. 26, # 2 p. 179 - 188 |
|
~41%
3-乙酰基-2-氯-1-甲基吲哚 65287-75-4 |
| 文献:Liegault, Benoit; Petrov, Ivan; Gorelsky, Serge I.; Fagnou, Keith Journal of Organic Chemistry, 2010 , vol. 75, # 4 p. 1047 - 1060 |
|
~%
3-乙酰基-2-氯-1-甲基吲哚 65287-75-4 |
| 文献:Deng; Konopelski Organic letters, 2001 , vol. 3, # 19 p. 3001 - 3004 |
|
~%
3-乙酰基-2-氯-1-甲基吲哚 65287-75-4 |
| 文献:Monge; Palop; Ramirez; Font; Fernandez-Alvarez European Journal of Medicinal Chemistry, 1991 , vol. 26, # 2 p. 179 - 188 |
|
~%
详细
|
| 文献:Liegault, Benoit; Petrov, Ivan; Gorelsky, Serge I.; Fagnou, Keith Journal of Organic Chemistry, 2010 , vol. 75, # 4 p. 1047 - 1060 |
| 3-乙酰基-2-氯-1-甲基吲哚上游产品 10 | |
|---|---|
| 3-乙酰基-2-氯-1-甲基吲哚下游产品 2 | |
| 3-acetyl-2-chloro-1-methylindole |
| 1-(2-chloro-1-methyl-indol-3-yl)-ethanone |
| 3-acetyl-2-chloro-N-methylindole |
| Ethanone,1-(2-chloro-1-methyl-1H-indol-3-yl) |
| 1-(2-chloro-1-methyl-1H-indol-3-yl)ethanone |
| N-methyl-2-chloro-3-acetylindole |